Gene Therapy Program | University of Pennsylvania Revenue and Competitors
Estimated Revenue & Valuation
- Gene Therapy Program | University of Pennsylvania's estimated annual revenue is currently $36M per year.
- Gene Therapy Program | University of Pennsylvania's estimated revenue per employee is $155,000
Employee Data
- Gene Therapy Program | University of Pennsylvania has 232 Employees.
- Gene Therapy Program | University of Pennsylvania grew their employee count by -14% last year.
Gene Therapy Program | University of Pennsylvania's People
Name | Title | Email/Phone |
---|---|---|
1 | Sr. Director Process Development | Reveal Email/Phone |
2 | Associate Director, Immunology Core | Reveal Email/Phone |
3 | Executive Director, Quality Assurance | Reveal Email/Phone |
4 | Director, Immunology Discovery Research | Reveal Email/Phone |
5 | Director, Stability Programs | Reveal Email/Phone |
6 | Senior Director Downstream | Reveal Email/Phone |
7 | Associate Director, Translational Research | Reveal Email/Phone |
8 | Associate Director Regulatory Affairs | Reveal Email/Phone |
9 | Associate Director Physical/Chemical Characterization | Reveal Email/Phone |
10 | Executive Director | Reveal Email/Phone |
Gene Therapy Program | University of Pennsylvania Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.6M | 10 | 0% | N/A | N/A |
#2 | $4M | 26 | 13% | N/A | N/A |
#3 | $0.9M | 6 | -14% | N/A | N/A |
#4 | $1.1M | 7 | 0% | N/A | N/A |
#5 | $10.9M | 70 | 3% | N/A | N/A |
#6 | $0.7M | 9 | 29% | N/A | N/A |
#7 | $4M | 26 | -16% | N/A | N/A |
#8 | $1.7M | 11 | 22% | N/A | N/A |
#9 | $7.6M | 49 | 2% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Gene Therapy Program | University of Pennsylvania?
Dedicated to discovery + translational research and led by Dr James Wilson, the Gene Therapy Program at the University of Pennsylvania focuses on the development of next-generation gene transfer vectors and their application in the treatment of a variety of acquired and inherited diseases. Jim’s commitment to patients with rare diseases stemmed from his days as a graduate student and medical student at the University of Michigan between 1977 and 1984. He was discouraged by the lack of available treatments for rare disease patients but optimistic that science could yield solutions with his initial focus being gene therapy. He completed his training in Internal Medicine at the Massachusetts General Hospital followed by a postdoctoral fellowship at the Whitehead Institute where he began his work in gene therapy. After launching his faculty career in the Howard Hughes Medical Institute and the University of Michigan, he moved to the University of Pennsylvania in 1993. Jim’s laboratory has made seminal contributions to the technology of gene transfer and has paved the way for translation of these technologies into the clinic. He has published over 550 papers and is named on over 110 patents. Today, the goals of the Gene Therapy Program - to develop and commercialize transformative, genetic-based therapeutics - are driven by the unmet needs of patients with inherited genetic diseases. The Gene Therapy Program currently employs over 200 full-time employees with an annual operating budget based on funding from a diverse group of public and private sponsors.
keywords:N/AN/A
Total Funding
232
Number of Employees
$36M
Revenue (est)
-14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Gene Therapy Program | University of Pennsylvania News
Title: Preparation for a Gene Therapy Trial for LCA5-Associated Retinal ... University of Pennsylvania Perelman School of Medicine.
In a recently released study, doctors at the University of Pennsylvania said a gene therapy they developed has cured two men of a deadly...
Top University officials allegedly manipulated a Perelman School of ... of workplace abuse allegations within the Gene Therapy Program in...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15M | 232 | N/A | N/A |
#2 | $69.5M | 234 | 4% | N/A |
#3 | $56.6M | 234 | 4% | N/A |
#4 | $33.5M | 234 | -9% | $67.7M |
#5 | $69.8M | 235 | 3% | N/A |